130 Infos zu Christian Wandersee

25 Aktuelle Nachrichten

— Christian Wandersee, CEO von vasopharm, kommentierte: „Nach der Empfehlung des Data Monitoring Committee (DMC), die NOSTRA-III-Studie — Christian Wandersee, CEO von vasopharm, kommentierte: „Nach der Empfehlung des Data Monitoring Committee (DMC), die NOSTRA-III-Studie ...

Contact Person: Christian Wandersee. Address / PO Box: Friedrich-Bergius-Ring Postal Code / City: Wuerzburg. State: Bavaria. Country: Germany. Contact Person: Christian Wandersee. Address / PO Box: Friedrich-Bergius-Ring Postal Code / City: Wuerzburg. State: Bavaria. Country: Germany.

Christian Wandersee, Vasopharm GmbH | Dr. Holger Zimmermann, AiCuris. Anti-Infective Cures GmbH | Peter Llewellyn-Davis, APEIRON Biologics AG |. Deborah ... Christian Wandersee, Vasopharm GmbH | Dr. Holger Zimmermann, AiCuris. Anti-Infective Cures GmbH | Peter Llewellyn-Davis, APEIRON Biologics AG |. Deborah ...

Gründer Christian Wandersee (vasopharm GmbH) und Investor Andreas Huber (Bayern Kapital) sprechen über Tipps und Tricks für eine erfolgreiche ... Gründer Christian Wandersee (vasopharm GmbH) und Investor Andreas Huber (Bayern Kapital) sprechen über Tipps und Tricks für eine erfolgreiche ...

10 Profile in Sozialen Netzwerken

Werden Sie Mitglied von LinkedIn und erhalten Sie Zugriff auf das vollständige Profil von Christian Wandersee. Völlig kostenlos! Als Mitglied von LinkedIn ...

Sehen Sie sich das berufliche Profil von Christian Wandersee (Deutschland) auf LinkedIn an. LinkedIn ist das weltweit ... Wandersee. CEO vasopharm GmbH.

Österreich · Tfzf · Consulting&CoachingChristian Wandersee. Würzburg und Umgebung · Christian See. A&W Indonesia. Jakarta, Indonesien · Christian See. Geschäftsführer. Deutschland · Christian Seeringer.

10 Hobbys & Interessen

Christian Wandersee · Selbstbestimmungsgesetz beschlossen – Proteste vor dem Bundestag · Thailändische Central-Gruppe kauft KaDeWe-Immobilie · Jennison Associates ... Christian Wandersee · Selbstbestimmungsgesetz beschlossen – Proteste vor dem Bundestag · Thailändische Central-Gruppe kauft KaDeWe-Immobilie · Jennison Associates ...

Christian Wandersee, Chief Executive Officer of vasopharm, commented: "Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we ... Christian Wandersee, Chief Executive Officer of vasopharm, commented: "Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we ...

— Christian Wandersee, Chief Executive Officer of vasopharm, commented: "Following the DMC recommendation to continue the NOSTRA III trial as — Christian Wandersee, Chief Executive Officer of vasopharm, commented: "Following the DMC recommendation to continue the NOSTRA III trial as ...

— Christian Wandersee, Chief Executive Officer of vasopharm, commented: "We welcome the recruitment of the first patient in to this pivotal — Christian Wandersee, Chief Executive Officer of vasopharm, commented: "We welcome the recruitment of the first patient in to this pivotal ...

1 Business-Profile

Christian Wandersee (Vasopharm GmbH). Wandersee, Christian (Vasopharm GmbH Managing Director). Organisation, Vasopharm GmbH. Product ... Christian Wandersee (Vasopharm GmbH). Wandersee, Christian (Vasopharm GmbH Managing Director). Organisation, Vasopharm GmbH. Product ...

2 Dokumente

MagForce AG · Christian Wandersee, Vasopharm GmbH ·. Dr. Wolfgang Weitnauer, Weitnauer Rechtsanwälte · Dr. Jörg. Zätzsch, CMS Hasche Sigle Partnerschaft von ... MagForce AG · Christian Wandersee, Vasopharm GmbH ·. Dr. Wolfgang Weitnauer, Weitnauer Rechtsanwälte · Dr. Jörg. Zätzsch, CMS Hasche Sigle Partnerschaft von ...

von I für die Schädlingsbekämpfung · — Gründers aus dem IGZ: Christian Wandersee, Geschäftsführer der Firma vasopharm, erzählte von seinen Erfahrungen. Noch als BWL-Student hat ... von I für die Schädlingsbekämpfung · — Gründers aus dem IGZ: Christian Wandersee, Geschäftsführer der Firma vasopharm, erzählte von seinen Erfahrungen. Noch als BWL-Student hat ...

4 Wissenschaftliche Publikationen

— Die Daten der vorangegangenen Phase II-Studie seien sehr genau analysiert worden, berichtet Firmenchef Christian Wandersee: „Wir glauben — Die Daten der vorangegangenen Phase II-Studie seien sehr genau analysiert worden, berichtet Firmenchef Christian Wandersee: „Wir glauben ...

Christian Wandersee von der vasopharm BIOTECH GmbH, Gewinner der letzten Runde: “Die Prämierung verschafft uns ein kaum zu unterschätzendes Argument gegenüber ...

Universität Würzburg: Mitteilungsblatt UNI-INTERN April

Christian Wandersee wird auch auf der Auftaktpressekonferenz anwesend sein und zu seinen Erfahrungen mit Science4Life berichten. Vom Auftakt der aktuellen Runde ...

4 Allgemeine Veröffentlichungen

CEO Christian Wandersee explains the hurdles and hopes when developing drugs for traumatic brain injury, a devastating condition for which there is no ... CEO Christian Wandersee explains the hurdles and hopes when developing drugs for traumatic brain injury, a devastating condition for which there is no ...

WebChristian Wandersee, Chief Executive Officer of vasopharm, commented: “We are very pleased and surprised by these results. Working closely with world experts in TBI, the …

WebChristian Wandersee CEO vasopharm GmbH Friedrich-Bergius-Ring Wuerzburg – Germany Phone: + Title: Microsoft …

WebChristian Wandersee, CEO Tel: + Optimum Strategic Communications Mary Clark, Eva Haas, Hollie Vile Tel: +44 (0) 203 …

3 Video- & Audioinhalte

The new capital will be used to commence a phase III study in moderate to severe traumatic brain injury

Mit dem frischen Kapital will Vasopharm seinen am weitesten fortgeschrittenen Produktkandidaten VAS203 gegen traumatische Hirnverletzungen in einer klinischen...

· ... einer möglichen Einreichung klinischer Daten im Jahr abzuschließen", kommentierte Christian Wandersee, CEO von Vasopharm.

4 Meinungen & Artikel

vasopharm CEO, Christian Wandersee provides an 'Expert View' on the difficulties involved in drug development in #TBI. vasopharm has the most advanced ... vasopharm CEO, Christian Wandersee provides an 'Expert View' on the difficulties involved in drug development in #TBI. vasopharm has the most advanced ...

— Make It Ten №5 is with Christian Wandersee, CEO of the most recent investment of our CV IV fund: vasopharm. Hopefully, as a private person — Make It Ten №5 is with Christian Wandersee, CEO of the most recent investment of our CV IV fund: vasopharm. Hopefully, as a private person ...

Seite 10 der Diskussion 'TFG - Der Pusher-Thread - für Kritiker verboten!' vom im w:o-Forum 'Nebenwerte Deutschland'.

59 Webfunde aus dem Netz

Presently, Christian Wandersee is Co-Managing Director & Chief Executive Officer at vasopharm GmbH. In the past he was Principal at VARTA BATTERIE AG. Presently, Christian Wandersee is Co-Managing Director & Chief Executive Officer at vasopharm GmbH. In the past he was Principal at VARTA BATTERIE AG.

Hier finden Sie die internationalen, operativen und branchenspezifischen Erfahrungen von Christian Wandersee. 3 bekannte Positionen zusätzlich zu Chief ... Hier finden Sie die internationalen, operativen und branchenspezifischen Erfahrungen von Christian Wandersee. 3 bekannte Positionen zusätzlich zu Chief ...

About. Vasopharm's CEO and Executive Team includes Frank Tegtmeier and 2 others. Team members. Christian Wandersee's profile picture. Christian Wandersee. About. Vasopharm's CEO and Executive Team includes Frank Tegtmeier and 2 others. Team members. Christian Wandersee's profile picture. Christian Wandersee.

Vasopharm's Leadership Team includes John Stover and 7 others. Team members. Christian Wandersee's profile picture. Christian Wandersee. CEO. Vasopharm's Leadership Team includes John Stover and 7 others. Team members. Christian Wandersee's profile picture. Christian Wandersee. CEO.

In Make It Ten №5 we spoke with Christian Wandersee, CEO of vasopharm, the most recent investment out of our CV IV fund. In Make It Ten №5 we spoke with Christian Wandersee, CEO of vasopharm, the most recent investment out of our CV IV fund.

Top vasopharm GmbH Employees ; Christian Wandersee. CEO at vasopharm GmbH. Würzburg, BY, DE ; Frank Tegtmeier. Chief Scientific Officer at vasopharm GmbH. Top vasopharm GmbH Employees ; Christian Wandersee. CEO at vasopharm GmbH. Würzburg, BY, DE ; Frank Tegtmeier. Chief Scientific Officer at vasopharm GmbH.

CEO Christian Wandersee explains the hurdles and hopes whe... Is trouble on the horizon for GSK? Ana Nicholls asks whether GSK's revenue drop is a short-te ... CEO Christian Wandersee explains the hurdles and hopes whe... Is trouble on the horizon for GSK? Ana Nicholls asks whether GSK's revenue drop is a short-te ...

Christian Wandersee, Chief Executive Officer of vasopharm, commented: “Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we ... Christian Wandersee, Chief Executive Officer of vasopharm, commented: “Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we ...

Christian Wandersee and John Stover from Vasopharm talk to Pharmafile about the effects a Traumatic Brain Injury (TBI) can have on a patient, as well as the ... Christian Wandersee and John Stover from Vasopharm talk to Pharmafile about the effects a Traumatic Brain Injury (TBI) can have on a patient, as well as the ...

... Christian Wandersee SV Krefeld 72 am Wochenende wieder im Doppeleinsatz. Pokalspiel in Hildesheim / Bundesligaduell beim Aufsteiger Poseidon Hamburg Christian Wandersee SV Krefeld 72 am Wochenende wieder im Doppeleinsatz. Pokalspiel in Hildesheim / Bundesligaduell beim Aufsteiger Poseidon Hamburg.

Christian Wandersee, Chief Executive Officer of vasopharm, commented: "We welcome the recruitment of the first patient in to this pivotal phase III trial. Christian Wandersee, Chief Executive Officer of vasopharm, commented: "We welcome the recruitment of the first patient in to this pivotal phase III trial.

... Christian Wandersee, CEO of vasopharm. “In the Phase IIa NOSTRA trial, we ... Christian Wandersee, CEO vasopharm GmbH. Phone: + Email Christian Wandersee, CEO of vasopharm. “In the Phase IIa NOSTRA trial, we ... Christian Wandersee, CEO vasopharm GmbH. Phone: + Email ...

Christian Wandersee, Chief Executive Officer of vasopharm, commented: “Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we ... Christian Wandersee, Chief Executive Officer of vasopharm, commented: “Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we ...

Christian Wandersee (CEO) | Frank Tegtmeier (Chief Scientific Officer) | Andrew Clark (Chairman) | View more for vasopharm GmbH >>> Christian Wandersee (CEO) | Frank Tegtmeier (Chief Scientific Officer) | Andrew Clark (Chairman) | View more for vasopharm GmbH >>>

Company management. Management. Dr. Frank Tegtmeier Christian Wandersee. Commercial register. HRB 6241, Würzburg. Tax ID no. DE Further ... Company management. Management. Dr. Frank Tegtmeier Christian Wandersee. Commercial register. HRB 6241, Würzburg. Tax ID no. DE Further ...

Christian Wandersee, Chief Executive Officer of vasopharm, says: “Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we are ... Christian Wandersee, Chief Executive Officer of vasopharm, says: “Following the DMC recommendation to continue the NOSTRA III trial as per protocol, we are ...

... Christian Wandersee GF Frank Tegtmeier Kapital: € Satzung Kapital: € Kapital: € Kapital: € Kapital: € Satzung Christian Wandersee GF Frank Tegtmeier Kapital: € Satzung Kapital: € Kapital: € Kapital: € Kapital: € Satzung ...

— Verbundene Manager: Bernd Burger, Christian Wandersee, Frank Tegtmeier · Ulrich Walter, Genthin. Aktiv. 1. Aktive Verbindungen: AWO fair.leben — Verbundene Manager: Bernd Burger, Christian Wandersee, Frank Tegtmeier · Ulrich Walter, Genthin. Aktiv. 1. Aktive Verbindungen: AWO fair.leben ...

— In Make It Ten №5 we spoke with Christian Wandersee, CEO of vasopharm, the most recent investment out of our CV IV… Read more… — In Make It Ten №5 we spoke with Christian Wandersee, CEO of vasopharm, the most recent investment out of our CV IV… Read more…

— ... Christian Wandersee, CEO of vasopharm. “We are pleased to welcome Creathor Ventures to vasopharm and would like to thank our existing — ... Christian Wandersee, CEO of vasopharm. “We are pleased to welcome Creathor Ventures to vasopharm and would like to thank our existing ...